Evidence map›Paper›PMID 35566388›Full record

ReviewMolecules (Basel, Switzerland)2022

Rediscovering the Therapeutic Potential of Agarwood in the Management of Chronic Inflammatory Diseases.

Juman Mohammed Rasmi Alamil, Keshav Raj Paudel, Yinghan Chan, Dikaia Xenaki, Jithendra Panneerselvam, Sachin Kumar Singh, Monica Gulati, Niraj Kumar Jha, Deepak Kumar, Parteek Prasher and 6 more

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 3 countries.

Juman Mohammed Rasmi AlamilSchool of Postgraduate Studies, International Medical University (IMU), Kuala Lumpur 57000, Malaysia.ORCID 0000-0003-1022-043X
Keshav Raj PaudelCentre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW 2007, Australia.ORCID 0000-0002-3591-2080
Yinghan ChanSchool of Pharmacy, International Medical University (IMU), Kuala Lumpur 57000, Malaysia.ORCID 0000-0001-8405-8637
Dikaia XenakiWoolcock Institute of Medical Research, University of Sydney, Sydney, NSW 2006, Australia.
Jithendra PanneerselvamDepartment of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Kuala Lumpur 57000, Malaysia.
Sachin Kumar SinghSchool of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144411, India.ORCID 0000-0003-3823-6572
Monica GulatiSchool of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144411, India.
Niraj Kumar JhaDepartment of Biotechnology, School of Engineering & Technology (SET), Sharda University, Greater Noida 201310, India.ORCID 0000-0001-9486-4069
Deepak KumarDepartment of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Shoolini University, Solan 173229, India.
Parteek PrasherDepartment of Chemistry, University of Petroleum & Energy Studies, Dehradun 248007, India.ORCID 0000-0002-9412-9424
Gaurav GuptaSchool of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur 302017, India.
Raniya MalikDeÁurora Pty Ltd., Dean, VIC 3363, Australia.
Brian George OliverWoolcock Institute of Medical Research, University of Sydney, Sydney, NSW 2006, Australia.ORCID 0000-0002-7122-9262
Philip Michael HansbroCentre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW 2007, Australia.ORCID 0000-0002-4741-3035
Kamal DuaWoolcock Institute of Medical Research, University of Sydney, Sydney, NSW 2006, Australia.ORCID 0000-0002-7507-1159
Dinesh Kumar ChellappanDepartment of Life Sciences, School of Pharmacy, International Medical University (IMU), Kuala Lumpur 57000, Malaysia.ORCID 0000-0001-5567-6663
IMU University · MYUniversity of Technology Sydney · AULovely Professional University · INSharda University · INShoolini University · INThe University of Sydney · AUUniversity of Petroleum and Energy Studies · INUttaranchal University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The inflammatory response is a central aspect of the human immune system that acts as a defense mechanism to protect the body against infections and injuries. A dysregulated inflammatory response is a major health concern, as it can disrupt homeostasis and lead to a plethora of chronic inflammatory conditions. These chronic inflammatory diseases are one of the major causes of morbidity and mortality worldwide and the need for them to be managed in the long term has become a crucial task to alleviate symptoms and improve patients' overall quality of life. Although various synthetic anti-inflammatory agents have been developed to date, these medications are associated with several adverse effects that have led to poor therapeutic outcomes. The hunt for novel alternatives to modulate underlying chronic inflammatory processes has unveiled nature to be a plentiful source. One such example is agarwood, which is a valuable resinous wood from the trees of

Indexed as

Quality of LifeThymelaeaceaeAnti-Inflammatory AgentsHumansInflammationPlant ExtractsWoodAnti-Inflammatory AgentsPlant Extractsagarwoodagarwood oilanti-inflammatoryherbsinflammationtherapeutics

Identifiers

PMID35566388
PMCPMC9104417
OpenAlexW4229439684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.